Clinical Trial Update: Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating perioperative chemotherapy with docetaxel, cisplatin, and capecitabine (DCX) for gastric cancer and esophageal cancer; status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Capecitabine (capecitabine)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Gastric Cancer, Esophageal Cancer | Phase 2 | Status: UNKNOWN